M&T Bank
BMY.RT

M&T Bank’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

M&T Bank’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-54,542
Closed -$38K – 1774
2020
Q4 		$38K Sell
54,542
-14,606
-21% -$31.1K ﹤0.01% 1611
2020
Q3 		$155K Sell
69,148
-5,306
-7% -$15.2K ﹤0.01% 1458
2020
Q2 		$267K Sell
74,454
-2,535
-3% -$9.15K ﹤0.01% 1248
2020
Q1 		$292K Buy
+76,989
New +$254K ﹤0.01% 1143

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

M&T Bank's BMY.RT Position: Q1 2021 in Review

M&T Bank sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 54,542 shares — an estimated $38K sold.

M&T Bank first reported a position in BMY.RT in Q1 2020 and held it in 4 quarters. The position peaked at $292K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • M&T Bank reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • M&T Bank sold 54,542 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $38K.
  • M&T Bank first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q1 2020 and held it in 4 quarters.
  • M&T Bank's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $292K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on M&T Bank's 13F filing for Q1 2021, filed 6 May 2021.